Small Caps Dashboard
 

PHARMAXIS


Sector: Biotech

Industry: Drug developer

Pharmaxis is an Australian pharmaceutical research company focussed on development drugs for inflammation and fibrotics diseases. The company has licenced two products: Bronchitol used to treat cystic fibrosis and marketed in Australia, Europe and Russia with US FDA approval pending; and Aridol, a lung function test for the assessment and diagnosis of asthma, marketed in Asia, Australia, Europe and US. The company has a pipeline of five drugs at various stages of development.

**FY20 Forecast

See our recomndations.
Unlock

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec porttitor semper molestie. Ut eleifend, erat eu pulvinar iaculis, odio nunc venenatis tellus, ut placerat lorem purus sed tellus. Duis ut leo vitae massa facilisis dictum sed a dui. Proin quis pulvinar purus, vestibulum lobortis justo.

 
  • Radar Rating Unlock
  • Market Cap ($m)* 37.3
  • Dividend Yield (%)* 0
  • NET CASH ($M) 9.7
  • * Data as of 24 January 2021

Latest Research Summary

PHARMAXIS: RESEARCH TIP UPDATES - NOVEMBER 2020
05 Nov, 2020

Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Maecenas ut ex et est semper fringilla. Nam et lectus augue. Integer non consectetur ligula. Maecenas tortor metus, molestie at aliquam sit amet, feugiat sed ipsum. Donec vehicula mi ac neque tempor dignissim.

Unlock to view the latest research

Previous Research

Research Date Radar Rating  
PHARMAXIS: RESEARCH TIP UPDATES - NOVEMBER 2020 05 Nov, 2020 8b824633 View Research
PHARMAXIS: RESEARCH TIP UPDATE - JULY 2020 15 Jul, 2020 9df9ea9d View Research
PHARMAXIS: RESEARCH TIP UPDATE - JULY 2020 402 02 Jul, 2020 4f807964 View Research
PHARMAXIS: RESEARCH TIP UPDATE - JANUARY 2020 16 Jan, 2020 91c7ec6e View Research
PHARMAXIS: RESEARCH TIP UPDATES - AUGUST 2019 21 Aug, 2019 b8b70c83 View Research
PHARMAXIS: RESEARCH TIP UPDATES - MAY 2019 08 May, 2019 572c400a View Research
PHARMAXIS: RESEARCH TIP UPDATES - FEBRUARY 2019 06 Feb, 2019 eb48a9f3 View Research
PHARMAXIS: RESEARCH TIP UPDATES - NOVEMBER 2018 21 Nov, 2018 83fe7439 View Research
PHARMAXIS: RESEARCH TIP UPDATE - OCTOBER 2018 24 Oct, 2018 74fc0e25 View Research
PHARMAXIS: RESEARCH TIP UPDATES - AUGUST 2018 08 Aug, 2018 733ccff8 View Research
PHARMAXIS: HEALTH AND BIOTECH - APRIL 2018 05 Apr, 2018 857b3557 View Research
PHARMAXIS: RESEARCH TIP UPDATES - NOVEMBER 2017 08 Nov, 2017 0e4a960c View Research
PHARMAXIS: RESEARCH TIP UPDATE - SEPTEMBER 2017 14 Sep, 2017 6428cb7a View Research
PHARMAXIS: REPORTING SEASON - AUGUST 2017 17 Aug, 2017 caa02d7b View Research
PHARMAXIS: RESEARCH TIP UPDATE - JULY 2017 06 Jul, 2017 b949fb56 View Research
PHARMAXIS: RESEARCH TIP UPDATE - JUNE 2017 15 Jun, 2017 0cc8c6b6 View Research
PHARMAXIS: RESEARCH TIP UPDATE - MAY 2017 18 May, 2017 1d198beb View Research
PHARMAXIS: BIOTECH SPECIAL REPORT - FEBRUARY 2017 08 Feb, 2017 aa20c2ac View Research
PHARMAXIS: RESEARCH UPDATE - AUGUST 2016 25 Aug, 2016 d49520cc View Research
PHARMAXIS: INITIAL - MARCH 2016 29 Mar, 2016 bfbe1e8b View Research
PHARMAXIS 25 Sep, 2014 9266b5c4 View Research
PHARMAXIS 22 Feb, 2014 0aa0d9af View Research
PHARMAXIS 13 Jun, 2013 318aeb8e View Research